Singapore markets closed

Vaccinex, Inc. (VCNX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.75+0.05 (+0.88%)
At close: 04:00PM EDT
6.00 +0.25 (+4.35%)
After hours: 06:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 9.11M
Enterprise value 7.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.68
Price/book (mrq)3.05
Enterprise value/revenue 276.08
Enterprise value/EBITDA -0.72

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-93.15%
S&P500 52-week change 326.27%
52-week high 3100.80
52-week low 34.43
50-day moving average 36.80
200-day moving average 317.45

Share statistics

Avg vol (3-month) 313.08k
Avg vol (10-day) 35.19k
Shares outstanding 51.58M
Implied shares outstanding 61.67M
Float 8591.01k
% held by insiders 16.77%
% held by institutions 141.49%
Shares short (30 Apr 2024) 412.99k
Short ratio (30 Apr 2024) 41.27
Short % of float (30 Apr 2024) 41.57%
Short % of shares outstanding (30 Apr 2024) 40.82%
Shares short (prior month 28 Mar 2024) 46.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:14
Last split date 320 Feb 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,014.91%

Management effectiveness

Return on assets (ttm)-246.44%
Return on equity (ttm)-1,405.34%

Income statement

Revenue (ttm)570k
Revenue per share (ttm)1.23
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -22.77M
Net income avi to common (ttm)-20.25M
Diluted EPS (ttm)-43.68
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.53M
Total cash per share (mrq)1.25
Total debt (mrq)247k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.57
Book value per share (mrq)-2.59

Cash flow statement

Operating cash flow (ttm)-17.23M
Levered free cash flow (ttm)-11.11M